Trials / Completed
CompletedNCT03509896
Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Treatment Pattern, Clinical Outcome and Healthcare Resource Utilization Associated With Chinese Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP): A Retrospective Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 463 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational medical record review of newly diagnosed CML-CP participants in China
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional | Non-Interventional |
Timeline
- Start date
- 2017-11-30
- Primary completion
- 2019-06-07
- Completion
- 2019-09-28
- First posted
- 2018-04-26
- Last updated
- 2022-06-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03509896. Inclusion in this directory is not an endorsement.